Tech Company Financing Transactions
The Oncology Institute Funding Round
The Oncology Institute closed a $86 million funding round on 7/7/2026. Investors included Deerfield Capital and OrbiMed.
Transaction Overview
Company Name
Announced On
7/7/2026
Transaction Type
Debt
Amount
$86,000,000
Round
Undisclosed
Investors
OrbiMed (Matthew Rizzo)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
EdTech
Mailing Address
18000 Studebaker Rd
Cerritos, CA 90703
USA
Cerritos, CA 90703
USA
Phone
Undisclosed
Website
Email Address
Overview
The Oncology Institute, Inc. is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Our Mission: The Oncology Institute of Hope and Innovation heals and empowers patients through compassion, innovation, and state-of-the-art medical care. Our Vision: The Oncology Institute of Hope and Innovation strives to be the nation's leading value based oncology group.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Virnich
Chief Financial Officer
Rob Carter
Chief Information Officer
Rakesh Panda
Chief Medical Officer
Yale Podnos
Controller
Austin Lee
VP - Administration
Kristin England
VP - Bus. Development
Jordan McInerney
VP - Finance
Stephen Cella
VP - General Counsel
Minh Merchant
VP - Human Resources
Nolan Mariano
Browse more venture capital transactions:
Prev: 7/6/2026: Katalyze AI venture capital transaction
Next: 7/7/2026: Quaise Energy venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs